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ABSTRACT
Platelet-activating factor (PAF) can activate various cel-
lular functions, including degranulation in eosinophils.
In the present study, we examined tyrosine phosphory-
lation of intracellular proteins induced by PAF in
eosinophils derived from cord blood mononuclear
cells. Platelet-activating factor induced tyrosine phos-
phorylation of many intracellular proteins, including
42, 123 and 150 kDa proteins. Immunoprecipitation
studies showed that the 123 kDa phosphorylated
protein was proline-rich tyrosine kinase 2 (PYK-2; also
known as related adhesion focal tyrosine kinase
(RAFTK), cell adhesion kinase b ( CAKb) and calcium-
dependent tyrosine kinase (CADTK) ). Furthermore,
blocking of cellular adhesion through b 2 integrin by
anti-CD18 monoclonal antibody inhibited tyrosine
phosphorylation of PYK-2 as well as the degranulation
response. These findings suggest that tyrosine phos-
phorylation of PYK-2 is involved in a signaling pathway
mediated by cellular adhesion through b 2 integrin in
PAF-activated eosinophils.
Key words: degranulation, eosinophil, b 2 integrin,
PYK-2, tyrosine phosphorylation.
INTRODUCTION
Eosinophils are believed to play important roles in the
pathophysiology of allergic diseases, such as bronchial
asthma and atopic dermatitis.1,2 During inflammation in
these diseases, lipid mediators, such as leukotriene (LT)B43
and platelet-activating factor (PAF),4 and chemokines,
such as RANTES,5 monocyte chemotactic factor-36 and
eotaxin,7 induce eosinophil migration from the blood-
stream into the tissues. Subsequently, appropriate stimuli
activate eosinophils and provoke production and/or the
release of a number of pro-inflammatory mediators, such
as major basic protein, eosinophil-derived neurotoxin
(EDN), superoxide anion (O2–),8 LTC49 and cytokines.10
Tissue eosinophil infiltration and deposition of released
granule proteins are pathologic features of allergic dis-
eases.11,12 Although the triggers for eosinophil activation
in vivo are still unknown, recent in vitro studies suggest 
that immunoglobulins, such as secretory IgA (sIgA) and
IgG,13 cytokines, such as interleukin (IL)-5 and granulo-
cyte–macrophage colony stimulating factor (GM-CSF),14
and soluble mediators, such as PAF15 and C5a,16 potently
induce eosinophil degranulation.
Platelet-activating factor is a potent phospholipid
mediator that exerts various biological activities, such as
platelet activation, airway constriction, development of
bronchial hyperresponsiveness and induction of micro-
vascular leakage and edema. As a result of these
activities, PAF may play a role in the pathophysiology of
bronchial asthma. Platelet-activating factor induces
eosinophil chemotaxis and transmigration through the
basement membrane barrier17,18 and also stimulates
eosinophil effector functions, including not only the
release of cytotoxic granule proteins, but also the produc-
tion of O2–.15 Furthermore, PAF rapidly causes activation
of Mac-1 (a M/b 2) by changing the affinity to its ligand,19
and eosinophil effector functions induced by PAF are
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totally dependent on cellular adhesion through Mac-1
(a M/b 2).8 These observations suggest a key role for b 2
integrin in eosinophil activation induced by PAF.
Although tyrosine phosphorylation of proteins induced
by various stimuli is critical for signal transduction in
eosinophils, little is known about phosphorylated pro-
teins induced by PAF. A recent report suggested that
phosphatidylinositol 3-kinase (PI3K)–protein kinase B
(PKB) and p21ras–extracellular signal-regulated kinase
(ERK) signal transduction pathways were included in
PAF-activated eosinophils.20 It showed that the mitogen-
activated protein kinase (MAPK) p42ERK2 and protein
kinase (PK)B, known as a downstream target of PI3K
activation, were phosphorylated and activated by PAF.
Another study has indicated that PAF induces a marked
increase of tyrosine phosphorylation of undefined 
120 kDa protein(s).21 However, the relevance of tyrosine
phosphorylation and cellular adhesion was not des-
cribed in these reports.
We have recently shown that large numbers of eosin-
ophils were generated when cord blood mononuclear cells
(CBMC) were cultured with IL-3 and IL-5 in hyaluronic
acid-coated flasks.22 Using a large quantity of cells
obtained by this method, we performed biochemical analy-
sis for tyrosine phosphorylation in activated eosinophils.
Herein, we report that tyrosine phosphorylation of proline-
rich tyrosine kinase 223 (PYK-2; also called CAKb 24 and
related adhesion focal tyrosine kinase (RAFTK)25) was
induced by PAF in CBMC-derived eosinophils and this
phosphorylation and PAF-induced degranulation was
inhibited by blocking b 2 integrin using anti-CD18 anti-
body (Ab).
METHODS
Eosinophils
Cultured eosinophils were obtained from CBMC by
culture with IL-3 (omitted after 2 weeks) and IL-5 in
flasks coated with hyaluronic acid for 4–5 weeks as
described previously.22 More than 90% of cells were
eosinophils as judged by morphological analysis of
May–Giemsa staining of the cells. The contaminating
cells were myelocytes. The culture medium was
replaced 12–18 h before use with fresh medium that
did not contain IL-5. Peripheral eosinophils were
obtained from venous blood of normal volunteers using
a magnetic cell separation system (MACS; Becton-
Dickinson, Franklin Lakes, NJ, USA) as described
previously.26 Briefly, heparinized peripheral blood was
diluted with phosphate-buffered saline (PBS) and over-
laid on isotonic Percoll solution (density 1.082 g/mL).
After centrifugation, supernatants and mononuclear
cells were aspirated and erythrocytes in the sediments
were lyzed using hypotonic water. Isolated granulocytes
were washed with Pipes buffer (containing (in mmol/L):
Pipes 25; NaCl 50; KCl 5; NaOH 25; glucose 5.4; 
pH 7.4) with 1% defined calf serum (DCS) and anti-
CD16 Ab-conjugated magnetic beads (Miltenyi Biotec,
Auburn, CA, USA) were added. After 60 min on ice, the
cell/bead pellets were resuspended and loaded onto
the separation column in a strong magnetic field. Cells
were eluted with Pipes buffer with 1% DCS and were
washed once with the same buffer. The purity of
eosinophils counted by Randolph’s staining was > 99%.
Immunoblotting analysis
Immunoblotting analysis of phosphotyrosine-containing
protein was performed as described previously by
Kawakami et al.27 with minor modifications. Briefly, approx-
imately 1 · 107 eosinophils were preincubated in RPMI
1640 medium for 15 min in polystyrene tubes coated with
2.5% human serum albumin (HSA). Platelet-activating
factor (1 m mol/L) was added and cells were incubated for
the indicated time at 37°C. For Ab-blocking analysis, cells
were preincubated with mouse anti-CD18 monoclonal Ab
(6.9 m g/mL; subclass IgG1; code no. M0783; DAKO,
Glostrup, Denmark) or control Ab (6.9 m g/mL mouse
IgG1; code no. X0931; DAKO) before the addition of
stimulus. After stimulation, cells were collected by centri-
fugation and were lyzed with NP-40 lysis buffer. After 
30 min on ice, cells were centrifuged at 15 000 g for 
10 min at 4°C. Supernatants were mixed with Laemmli
loading buffer, boiled for 5 min and analyzed by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE; 8% gel). After electrophoresis, proteins in
the gels were blotted onto PVDF membranes (Millipore,
Tokyo, Japan) and probed with antiphosphotyrosine
monoclonal Ab (4G10; Upstate Biotechnology Inc.,
Lake Placid, NY, USA) and peroxidase-conjugated anti-
mouse IgG polyclonal Ab (Amersham Corp., Arlington
Heights, IL, USA). Immunoreactive proteins were visual-
ized using enhanced chemiluminescence detection
reagents (ECL; Amersham Corp.) and exposed to X-ray
film. For immunoprecipitation, anti-PYK-2 polyclonal Ab
(N-19; not cross-reactive with focal adhesion kinase
(FAK); Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA) was added to supernatants of lyzed eosinophils.
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After 2 h at 4°C, immune complexes were precipitated
using Protein A/G agarose (Santa Cruz Biotechnology
Inc.). Precipitated complexes were washed and mixed
with Laemmli loading buffer. After boiling for 
5 min, they were analyzed by SDS-PAGE and immuno-
blotted in a manner similar to that described for total cell
lysates. In some experiments, the films of immunoblots
were scanned using an image analyzer (LAS-1000; Fuji
Film Co. Ltd, Tokyo, Japan) and were analyzed on a
Macintosh computer (Apple Computer Inc., Cupertino,
CA, USA) with Image Gauge software (version 3.0; Fuji
Film) for densitometric analysis.
Eosinophil degranulation
Eosinophil degranulation was performed as described
previously.22 Briefly, cultured eosinophils were suspended
in RPMI 1640 medium and added to 96-well tissue
culture plates precoated with 2.5% HSA at 2 · 105
cells/well. After preincubation for 15 min, degranulation
of eosinophils was initiated by adding PAF at 1 m mol/L.
After incubation for 30 min, supernatants from wells were
collected and frozen at –30°C until assay. For blocking
experiments with Ab, anti-CD18 monoclonal Ab or
control Ab (6.9 m g/mL) was added to the wells before 
the addition of PAF. The concentration of EDN in the
supernatants from the wells was measured by ELISA as an
indicator of eosinophil degranulation.
Immunostaining of eosinophils
Purified peripheral eosinophils were washed with PBS
and fixed for 10 min at 4°C in 100% acetone. Fixed cells
were preincubated with 10% rabbit normal serum in 
PBS for 10 min and then incubated with primary anti-
body for 2 h at 20°C. Cells were then washed three
times with PBS. Next, the secondary antibody was
applied for 30 min at 20°C. After washing three times
with PBS, the coverslips were mounted in aqueous
mounting media (AquatexTM; Merck, Whitehouse
Station, NJ, USA). The primary antibody used was anti-
PYK-2 polyclonal Ab (N-19; Santa Cruz Biotechnology
Inc.) at 2 m g/mL. The secondary antibody was fluores-
cein-conjugated rabbit F(ab ¢ )2 antigoat IgG (Cappel,
Aurora, OH, USA; used at a 1 : 1000 dilution). Immuno-
fluorescence was imaged with a Zeiss LSM-510 confocal
laser scanning microscope (Carl Zeiss Microscopy, Jena,
Germany).
Statistical analysis
Results are expressed as the mean ± SEM. Statistical 
significance was analyzed by paired Student’s t-test. 
P < 0.05 was considered statistically significant.
RESULTS
Tyrosine phosphorylation of intracellular 
proteins induced by PAF in CBMC-derived
eosinophils
To analyze the tyrosine phosphorylation of intracellular
proteins, CBMC-derived eosinophils were stimulated with
PAF for the indicated times. The total cell lysates were
analyzed by immunoblotting with antiphosphotyrosine 
Ab (4G10). As shown in Fig. 1, PAF strongly and rapidly
induced tyrosine phosphorylation of several proteins,
including those at 42, 123 and 150 kDa, in 30 s. Phos-
phorylation of the 123 kDa protein was stronger than
that of the 150 kDa protein and remained at a high level
for at least 30 min. In preliminary experiments, non-
stimulated cell lysate at 30 min showed no change in
basal levels of phosphorylation (data not shown).
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Fig. 1 Kinetics of tyrosine phosphorylation of intracellular pro-
teins induced by platelet-activating factor (PAF). Eosinophils were
stimulated for the indicated times with PAF (1 m mol/L). Total cell
lysates were analyzed by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis and immunoblotting with antiphosphotyro-
sine antibody (4G10). The figure shows representative results of
three independent experiments with similar results.
Effects of blocking of b 2 integrin on tyrosine
phosphorylation of intracellular proteins and
the degranulation response of CBMC-derived
eosinophils
We have previously shown that cellular adhesion through
b 2 integrin (CD18) plays critical roles in activation of
peripheral blood eosinophils stimulated with PAF or
cytokines.8 Anti-CD18 antibody treated or non-adherent
eosinophils released much smaller amounts of granule
proteins than adherent eosinophils. Because tyrosine
phosphorylation of proteins serves as a critical upstream
signal for the degranulation response of eosinophils,28
we examined whether tyrosine phosphorylation of intra-
cellular proteins was affected by blocking of b 2 integrin
using anti-CD18 monoclonal Ab. As shown in Fig. 2a,
anti-CD18 monoclonal Ab, but not control Ab, strongly
inhibited tyrosine phosphorylation of the 123 kDa protein
and partially inhibited phosphorylation of the 42 kDa
protein. Phosphorylation of other proteins was minimally
affected by anti-CD18 monoclonal Ab, suggesting that
phosphorylation of the 123 and 42 kDa proteins was
dependent, or partially dependent, on cellular adhesion
through b 2 integrin. The differences in basal levels of
phosphorylation in Fig. 1 and Fig. 2a (lane 1 in both
figures) may have been caused by differences in the
source of cord blood; however, major tyrosine phospho-
rylated proteins, such as 42, 123 and 150 kDa, were
common and significant.
Next, we examined the effects of anti-CD18 mono-
clonal Ab on degranulation of CBMC-derived eosinophils.
As shown in Fig. 2b, CBMC-derived eosinophils were also
degranulated by PAF and the degranulation was signifi-
cantly inhibited by anti-CD18 monoclonal Ab (71.1%
inhibition), but not by control Ab (17.1% inhibition).
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Fig. 2 Effects of blocking of b 2 integrin on (a) tyrosine phos-
phorylation of intracellular proteins induced by platelet-
activating factor (PAF) and (b) eosinophil degranulation.
Eosinophils were preincubated with anti-CD18 monoclonal
antibody (Ab; lane 3), control Ab (lane 4) or without Ab (lanes 
1 and 2). Cells were then stimulated with (lanes 2, 3 and 4) 
or without (lane 1) 1 m mol/L PAF. (a) Total cell lysates were 
analyzed by sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis and immunoblot with antiphosphotyrosine antibody
(4G10). (b) The concentration of released eosinophil-derived
neurotoxin (EDN) in the supernatant was measured by ELISA.
Data are the mean ± SEM (n = 4). *P < 0.05. (h), no anti-
body; ( ), PAF; (j), anti-CD18 Ab; ( ), control Ab.
Tyrosine phosphorylation of PYK-2 and its
inhibition by blocking of b 2 integrin in 
PAF-activated eosinophils
Because the 123 kDa protein was tyrosine phosphorylated
in activated eosinophils and the phosphorylation was sig-
nificantly inhibited by blocking of b 2 integrin (Figs 1,2), we
attempted to identify the 123 kDa phosphorylated protein.
Previous reports have suggested that FAK is a 125 kDa
molecule with important roles in the integrin-dependent
signal transduction pathway.29 However, in eosinophils,
FAK is constitutively phosphorylated in unstimulated and
non-adherent conditions.30 Recently, PYK-2 was identified
as another member of the FAK family and was shown to 
be expressed in various cell types, including granulo-
cytes.23,24,30,31 Proline-rich tyrosine kinase 2 is highly
homologous to FAK and its integrin-dependent phosphory-
lation and activation have been characterized in several
cell types.32–34 Therefore, we examined the presence of
PYK-2 in CBMC-derived eosinophils. Reblotting using anti-
PYK-2 antibody showed the presence of PYK-2 in total cell
lysate (data not shown). Then, we investigated whether
PYK-2 was tyrosine phosphorylated in activated eosin-
ophils. In PAF-stimulated eosinophils, immunoprecipitation
and immunoblotting analysis showed that tyrosine phos-
phorylation of PYK-2 occurred within 30 s and remained 
at the same level for at least 30 min (Fig. 3). The kinetics 
of PYK-2 phosphorylation were similar to those of the 
123 kDa protein observed in total lysates (Fig. 1). Thus,
one of the tyrosine-phosphorylated proteins at approxi-
mately 123 kDa was likely to be PYK-2.
Then, we examined the effects of blocking of b 2 integrin
in PAF-activated eosinophils. As shown in Fig. 4a,b, PYK-2
was strongly tyrosine phosphorylated in PAF-stimulated and
adherent eosinophils and its phosphorylation was inhibited
by anti-CD18 Ab, while control Ab had no effect. Densi-
tometric analysis showed that inhibition of PYK-2
phosphorylation by anti-CD18 Ab was significant, while
control Ab showed no effect (inhibition 62 ± 22 vs
6 ± 18%, respectively; n = 3). These results indicate that
tyrosine phosphorylation of PYK-2 is dependent on cellular
adhesion through b 2 integrin in CBMC-derived eosinophils.
Immunostaining of PYK-2 in peripheral
eosinophils
Although granulocytes have been shown to express 
PYK-2,24 it is not clear whether peripheral eosinophils
also express this molecule. To confirm the existence of
PYK-2 in peripheral eosinophils, we stained purified
eosinophils with anti-PYK-2 antibody and fluorescein
isothiocyanate (FITC)-conjugated second antibody. In
this experiment, eosinophils were highly purified by neg-
ative selection using the MACS system with CD16
magnetic beads. The purity of eosinophils was 99.5%
as determined by counting 400 cells with Randolph’s
staining. Figure 5 shows the presence of PYK-2 in the
cytosol of peripheral eosinophils, while no staining was
observed in controls using the second antibody only
(data not shown).
DISCUSSION
In the present study, we showed that PYK-2 is phosphory-
lated in CBMC-derived eosinophils stimulated with PAF.
Interestingly, the phosphorylation of PYK-2 was inhibited
by anti-CD18 monoclonal Ab, suggesting that cellular
adhesion through b 2 integrin is required for phosphoryla-
tion of this protein.
Proline-rich tyrosine kinase 2 is an approximately 120
kDa cytoplasmic tyrosine kinase related to FAK and it is
widely distributed in various cells and tissues, including
peripheral blood leukocytes.23,24,25,31 Tyrosine phosphory-
lation and activation of PYK-2 is induced by thrombin in
megakaryotic cells25 and PYK-2 is physically associated
with several intracellular signaling molecules involved in
Src and MAPK signaling pathways.32 Recent reports have
suggested that PYK-2 is localized in focal contacts and
PHOSPHORYLATION OF PYK-2 IN EOSINOPHILS 249
Fig. 3 Kinetics of tyrosine phosphorylation of proline-rich
tyrosine kinase 2 (PYK-2) induced by platelet-activating factor
(PAF). Eosinophils were stimulated for the indicated times 
with PAF (1 m mol/L). Cell lysates were immunoprecipitated
with anti-PYK-2 antibody (Ab) and were then analyzed by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
and immunoblotting with antiphosphotyrosine Ab (4G10). The
figure shows representative results of three independent 
experiments with similar results.
that tyrosine phosphorylation of PYK-2 is modulated by
cellular adhesion via integrins in B lymphocytes, mega-
karyocytes and T lymphocytes.33–35 Furthermore, it has
been reported that phosphorylated PYK-2 is associated
with cytoskeletal proteins, such as paxillin and talin.36–38
These studies suggested that PYK-2 is an important signal-
ing molecule modulated by cellular adhesion via integrin.
In peripheral blood eosinophils, we demonstrated the
presence of PYK-2 in the cytosol and previously found that
ligation of b 2 integrin induced tyrosine phosphorylation of
several proteins of approximately 120 kDa, including 
c-Cbl and an as yet unidentified 115 kDa protein.30 Our
preliminary study also showed the 115 kDa protein was
immunoreactive with anti-PYK-2 Ab (data not shown).
Recent studies have shown that aggregation of b 1 integrin
in B lymphocytes and RBL-2H3 rat mast cells and b 3 inte-
grin in T lymphocytes results in tyrosine phosphorylation of
PYK-2.34,35 Furthermore, cytochalasin D, which disrupts
the cytoskeleton, inhibits PYK-2 tyrosine phosphorylation
in megakaryocytes.36 These observations indicate the
importance of tyrosine phosphorylation of PYK-2 in cellu-
lar adhesion via integrins. In fact, more recent studies
have indicated that PYK-2 phosphorylation is involved in
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Fig. 5 Immunostaining of proline-rich tyrosine kinase 2 
(PYK-2) in peripheral eosinophils. Purified peripheral
eosinophils were immunostained with anti-PYK-2. Images of
optical sections were obtained with a confocal laser scanning
microscope.
Fig. 4 Effects of blocking of b 2 integrin on tyrosine phosphorylation of proline-rich tyrosine kinase 2 (PYK-2) induced by platelet-
activating factor (PAF). (a) Eosinophils were preincubated with anti-CD18 monoclonal antibody (Ab; lane 3), control Ab (lane 4) or
without Ab (lanes 1 and 2). Cells were then stimulated with (lanes 2, 3 and 4) or without (lane 1) 1 m mol/L PAF. Cell lysates were
immunoprecipitated with anti-PYK-2 Ab and were then analyzed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and
immunoblotting with antiphosphotyrosine antibody (4G10). (b) Densitometric analysis of the results shown in panel (a). Results were
calibrated by the density of bands from the film probed with anti-PYK-2 antibody. The figure shows representative results of three
independent experiments with similar results. Cont. Ab, control antibody.
the signaling events in tumour necrosis factor-a - or 
N-formyl-methionyl-leucyl-phenylalanine-activated neu-
trophils subsequent to ligation of b 2 integrin.39,40 Thus,
the observations of the present study, as well as those
reported previously, strongly suggest that PYK-2 phos-
phorylation is involved in the signaling events of human
eosinophils subsequent to ligation of b 2 integrin.
We observed that anti-CD18 monoclonal antibody
inhibited both PYK-2 tyrosine phosphorylation and
degranulation of eosinophils8 induced by PAF. These
observations suggest that PYK-2 phosphorylation is
involved in the degranulation response of eosinophils.
Furthermore, we found that treatment of sIgA-conjugated
Sepharose 4B beads, a strong secretagogue for
eosinophils,13 also provoked PYK-2 tyrosine phosphory-
lation in CBMC-derived eosinophils (data not shown),
again suggesting an association between PYK-2 and
degranulation of eosinophils. A recent study showed that
activation of PYK-2 is involved in the signal transduction
pathway of RBL-2H3 cells stimulated through Fce RI.41
Although the molecular interactions between cell adhe-
sion molecules and Fc receptors are not clear, these
findings are consistent with the notion that PYK-2 tyrosine
phosphorylation may be associated with degranulation
responses of eosinophils and mast cells. Moreover, PYK-2
is activated by calcium ionophores or the protein kinase
C activator Phorbol myristate acetate,23 both of which
also potently stimulate eosinophil degranulation.42,43
Thus, it is possible that phosphorylation of PYK-2 plays a
role in degranulation of human eosinophils. Studies are
currently underway in our laboratory to investigate the
intracellular signaling pathway coupling PYK-2 activation
and the degranulation response of eosinophils.
In summary, we have investigated tyrosine phosphoryla-
tion of proteins stimulated with PAF using CBMC-derived
eosinophils. Our results show that tyrosine phosphorylation
of PYK-2 is involved in PAF-induced signaling pathways
and is dependent on cellular adhesion via b 2 integrin.
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